Company / Current Liabilities
BioLife Solutions, Inc. Current Liabilities History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$23.0M
FY2025
5-year range
$23.0M / $44.6M
FY2021-FY2025
Trend
-29.8%
vs FY2024
Sector context
#156 of 160
Health Care
What the data says
Among 160 Health Care companies, BioLife Solutions, Inc. is in the top 3% for current liabilities. Current Liabilities has declined for 3 consecutive years, from $45M in FY2022 to $23M in FY2025.
Based on SEC 10-K filings.
$23M in FY2025 with a 5-year CAGR of +8.1%.
Improved from $42M to $23M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -19.8%
- 5-Year CAGR
- +8.1%
- 10-Year CAGR
- -
Sector benchmark
Top 3% in Health CareTop 3% of 160This company $23.0M Sector average $4.5B
▼
-99.5% below sector average
Key checks
Key Insights
- BioLife Solutions, Inc.'s current liabilities has declined for 3 consecutive years.
- 5-year CAGR of +8.1%, indicating consistent growth.
- In FY2025, current liabilities decreased 29.8% year-over-year.
- Ranks #156 out of 160 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 4.67 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $23.0M | -29.8% |
| FY2024 | $32.7M | -22.4% |
| FY2023 | $42.2M | -5.4% |
| FY2022 | $44.6M | +4.4% |
| FY2021 | $42.7M | +174.2% |
| FY2020 | $15.6M | +103.1% |
| FY2019 | $7.7M | +484.5% |
| FY2018 | $1.3M | -13.3% |
| FY2017 | $1.5M | +33.5% |
| FY2016 | $1.1M | -34.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026